Showing 1,661 - 1,680 results of 100,411 for search '(( 5 ht decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.41s Refine Results
  1. 1661
  2. 1662
  3. 1663
  4. 1664
  5. 1665
  6. 1666
  7. 1667
  8. 1668
  9. 1669
  10. 1670
  11. 1671
  12. 1672
  13. 1673
  14. 1674
  15. 1675
  16. 1676
  17. 1677

    Image1_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  18. 1678

    Image3_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  19. 1679

    Image2_The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.JPEG by Yongqiang Liu (651861)

    Published 2024
    “…Herein, we report the characterization of the PrP-SCA7-92Q transgenic (Tg) line as a valuable CIPO mouse model and investigated the tolerability and efficacy of the 5-hydroxytryptamine type-4 receptor (5HT4R) agonist velusetrag as a promising pharmacological treatment for CIPO.…”
  20. 1680